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ABSTRACT: The novel thiourea-functionalized silicon nanoparticles (SiNPs) have been successfully synthesized using allylamine 
and sulforaphane, an important anticancer drug, followed by a hydrosilylation reaction on the surface of hydrogen terminated 
SiNPs. Their physiochemical properties have been investigated by photoluminescence emission, FTIR and elemental analysis. MTT 
assay has been employed to evaluate in vitro toxicity in colorectal cancer cells (Caco-2) and primary normal cells (CCD). The re-
sults show significant toxicity of thiourea SiNPs after 72 h incubation in the cancer cell line and the toxicity is concentration de-
pendent and saturated for concentrations above 100 µg/mL. Confocal microscopy images have demonstrated the internalization of 
thiourea-functionalized SiNPs inside the cells. Flow cytometry data has confirmed receptor-mediated targeting in cancer cells. This 
nanocomposite takes advantage of the EGFR active targeting of the ligand in addition to the photoluminescence properties of SiNPs 
for bioimaging purposes. The results suggest that this novel nanosystem can be extrapolated for active targeting of the receptors 
that are overexpressed in cancer cells such as EGFR using the targeting characteristics of thiourea-functionalized SiNPs and there-
fore encourage further investigation and development of anticancer agents specifically exploiting the EGFR inhibitory activity of 
such nanoparticles. 
1. Introduction 
 Conventional cancer chemotherapies have been associated 
with serious systemic toxicities and dose-limiting side effects 
that limit their clinical application.1 Targeted therapeutics on 
the other hand, by being more selective, can potentially mini-
mize the side effects of these anticancer agents.2-3 In efforts to 
develop targeted anticancer drugs, it is essential to consider 
many different aspects of molecular biology, such as the inter-
actions with cell surface receptors.4-5 Protein tyrosine kinases 
(PTKs) have been identified as major contributors in numer-
ous signal transduction pathways within cell membranes and 
are implicated in cell proliferation.6-7 Epidermal growth factor 
receptor (EGFR) kinase is one of the most important PTKs 
and plays a key role in a wide diversity of biological process-
es, including cell proliferation, metastasis, and angiogenesis.8-
10 Although EGFR is involved in various physiological pro-
cesses, and as such is expressed in non-malignant tissues, this 
tyrosine kinase has been shown to be over-expressed in tumors 
of epithelial origin such as colon, breast, ovarian, lung, and 
prostate cancer.11-12 Consequently, EGFR overexpression in 
cancerous tissue presents an attractive target for compounds 
with inhibitory activity. 
Among the anticancer drugs discovered in recent years, thi-
ourea compounds have shown potent anticancer properties 
owing to their strong inhibitory activity against receptor tyro-
sine kinases (RTKs), PTKs, and NADH oxidase which are all 
active in the process of tumorigenesis.10-11, 13 Here, for the first 
time we report the synthesis of thiourea-functionalized silicon 
nanoparticles (SiNPs) as a new multifunctional nanoscale sys-
tem.  By developing such hybrid nanoparticles, we can exploit 
the unique optical properties of SiNPs whilst introducing the 
targeting characteristics of the thiourea ligand for diagnostic 
applications.  One of the greatest challenges in nanomedicine, 
is defining the optimal targeting agents to selectively deliver 
nano-compounds to cancer tissues. Therefore, the capability of 
the targeting ligand to bind to the surface of the cancer cells is 
an important characteristic to trigger the receptor endocytosis. 
To this end, we herein report the synthesis and in vitro evalua-
tion of the targeting and toxicity activities of thiourea-
functionalized SiNPs. This approach investigates the ability of 
thiourea to target EGFR overexpression in cancer cells while 
taking advantage of the intrinsic photoluminescence properties 
of SiNPs, without the need for any fluorescent tags.  
SiNPs are heavy metal free in nature and exhibit visible 
photoluminescence as a result of the quantum confinement 
effect.14-17 The size tunable emission18-20, high brightness21, 
and high photostability compared to organic dyes22, have made 
SiNPs attractive materials as fluorescent cellular markers. In 
addition, silicon is abundant and economical23 but more im-
portantly silicon has low inherent toxicity. Studies report sili-
con to be almost ten times safer than cadmium-based counter-
parts for use in biomedical and bioimaging applications.24 
Unlike other semiconductors, silicon has an indirect band gap 
 that provides significant optical properties due to their very 
small size (about 4 nm), which is close to the bulk Bohr radi-
us.20, 25 
SiNPs have been prepared by a variety of physical and 
chemical approaches utilizing top down and bottom up tech-
niques such as electrochemical etching,26-27 thermal vaporiza-
tion,28 ion implantation,29 gas phase decomposition of 
silanes,30-31 and laser ablation.32 Bottom up techniques of pre-
paring NPs in solutions can simultaneously offer the control 
over the surface chemistry and particle size.33 However, con-
sideration of the challenges regarding sample purification is 
more important in terms of the biomedical applications. Thus, 
top down techniques such as electrochemical etching might be 
favourable in this regards to provide SiNPs with high purity.34 
In the present study, a thiourea ligand was synthesized fol-
lowed by hydrosilylation to functionalize SiNPs with this spe-
cific functional group. The hydrogen terminated SiNPs were 
first prepared through the electrochemical etching of porous 
silicon and later functionalized by thiourea. These functional-
ized SiNPs were tested in terms of cytotoxicity to colorectal 
cancer and primary cells and active EGFR-mediated targeting. 
In several respects, these novel nanoparticles offer significant 
advantages compared to conventional therapeutics. These in-
clude the integration of the targeting moiety and therapeutic 
moiety in the same system, the use of inexpensive materials 
and more importantly the production of a highly sta-
ble nanosystem. 
 
2. Experimental Methods 
2.1 General procedure for synthesis of thiourea-
functionalized SiNPs 
Hydrogen terminated SiNPs were synthesised by galvanos-
tatic anodization of porous Silicon layer (boron-doped p-Si 
(100) chip with 1.25 × 1.25 cm2 size) in a 1:1 v/v solution of 
48% aqueous HF and ethanol as reported previously.27  
Thiourea chain was obtained after 6 hrs refluxing of sul-
foraphane (4 μl, 0.0225 mmol) with 2 equivalent of allylamine 
(3.37 μl, 0.45 mmol) at RT in dry acetone under N2. The prod-
uct was reacted with hydrogen terminated SiNPs obtained 
from etching of 4 Silicon chips for extra 24 hours in EtOH at 
35 oC as described in Scheme 1. The mixture solution was 
centrifuged and the solvent was evaporated under the reduced 
pressure at 60 oC. 20 mg of thiourea-functionalized SiNPs was 
obtained from each batch. 
2.2 Chemical characterization  
Fourier transform infrared spectroscopy (FTIR) Meas-
urements were carried out using a Perkin-Elmer ATR-
FTIR spectrometer from the solid sample of thiourea-
functionalized SiNPs. The spectra were recorded after 16 
scans by correcting the background. 
X-ray photoelectron spectroscopy (XPS) measurements 
were performed on a K-Alpha XPS instrument (Thermo 
Scientific, East Grinstead, UK) at NEXUS. A few drops 
of the suspension of thiourea-functionalized SiNPs in 
EtOH were cast onto a cleaned gold substrate. The film 
was introduced into a load-lock attached to ultra-high 
vacuum (UHV) chamber in which the typical pressure 
was maintained below 5 × 10−9 mbar. All spectra were 
acquired at normal emission with AlKα radiation at 
1486.6 eV and a spot size of 400 m. A pass energy of 
200 eV and step size of 0.4 eV was used for the survey 
spectra and a pass energy of 40 eV and step size of 0.1 eV 
was used for high resolution spectra. In all photoemission 
spectra, binding energies (BEs) were referred to the Au 
4f7/2 line measured on a gold foil in direct electrical con-
tact with the sample which was found at binding energy 
of 84 eV. 
 
2.3 Particle size analysis and stability  
Transmission electron microscopy (TEM) studies were 
performed with the JEOL, JEM 2100 microscope running 
a LaB6 (lanthanum hexaboride crystal) emitter at voltage 
200 kV. TEM samples were prepared by drop-casting a 
dilute suspension of the sample dispersed in EtOH onto a 
200 mesh carbon-coated copper grid. The grids were 
dried before the measurement. TEM micrographs were 
taken at different spots of grids. 
The hydrodynamic diameter of thiourea-functionalized 
SiNPs and polydispersity index were determined by dy-
namic light scattering (DLS) measurement with Zetasizer 
Nano ZS (Malvern Instruments Ltd, UK) at room temper-
ature, equilibrating samples for 120 seconds prior to the 
measurement. 1 mg/mL of thiourea-functionalized SiNP 
solution was measured in distilled water and PBS, as well 
as RPMI and complete RPMI (supplemented with 10% 
FBS) media to assess the stability of the thiourea-
functionalized SiNPs under in vitro conditions.  Size 
measurements were performed in triplicates. Zeta poten-
tial was measured using the above protocol in water in the 
same instrument. 
 
2.4 Optical Characterization 
UV-Vis absorption (UV-Vis) and Photoluminescence 
(PL) spectroscopy were performed on thiourea-
functionalized SiNPs dispersed in EtOH. The UV-Vis 
absorption spectra of thiourea-functionalized SiNPs were 
recorded by a PerkinElmer 35 UV-vis double-beam spec-
trometer in a quartz cuvette (10×10 mm). The scan range 
was over a 300 to 700 nm at a rate of 900 nm/min and the 
spectra were corrected by subtracting the background 
contribution from the dispersing solvent. 
The PL spectra were collected using a Perkin Elmer 
LS55 spectrometer in a quartz cuvette (10×10 mm). The 
excitation wavelength was fixed at 340 nm with the exci-
tation and emission slit widths set at 10 nm. The emission 
spectra were corrected by the background spectra which 
was from the solvent emission. 
 
2.5 Cell culture  
Caco-2 (human colorectal adenocarcinoma) and CCD-
841 (human normal colon epithelial) cells were a kind gift 
from Dr Yongping Bao (Norwich Medical School, UK). 
Cells were sub-cultured in RPMI supplemented with 10% 
fetal bovine serum, 2 mM L-glutamine, 100 μg/mL peni-
cillin, and 100 μg/mL streptomycin (Life Technologies, 
Carlsbad, CA) and maintained in a humidified incubator 
at 37 oC within an atmosphere containing 5% CO2. Both 
cells tested negative for mycoplasma. 
 
                                                  
Si
 
Si
 
 
Scheme 1. Schematic illustration of (a) the chemical synthesis of thiourea ligand and (b) the conjugation of thiourea onto the 
surface of hydrogen capped silicon nanoparticles via hydrosilylation reaction. 
 
2.6 Cytotoxicity  
Cytotoxicity of thiourea-functionalised SiNPs was as-
sessed by standard MTT assay.35 Caco-2 and CCD cells 
were seeded in a 96-well culture plate at a seeding density 
of 4.5×104 cells per well. After 24 h the media was re-
moved and replaced with a range of different concentra-
tions of NPs suspension from 5 to 1500 µg/mL for 24 and 
72 h. The absorbance was measured using BMG Labtech 
Polar Star Optima microplate reader at 570 nm. Percent-
age of viable cells was calculated from a minimum of 
triplicate wells and normalized to untreated control cells. 
Results were expressed as mean ± SD of at least three 
independent experiments.36 
 
2.7 Cellular internalization by Laser scanning confocal 
microscopy 
Caco-2 cells were seeded on a 12-well plate with glass 
cover slips. Next day, cells were incubated with 100 
µg/mL of thiourea-functionalized SiNPs for 4 hours. Cells 
were washed and fixed with 4% (v/v) paraformaldehyde 
(PFA) (Sigma-Aldrich) in PBS solution for 20 min at 
room temperature. Nuclei were stained with Hoechst 
33342 (Sigma-Aldrich) (2 µg/mL) in PBS for 5 min. Ac-
tin was stained using Texas Red-X Phalloidin (Life Tech-
nologies) (6.6 µM). Laser scanning confocal microscopy 
was performed on a Zeiss LSM510 META confocal mi-
croscope using a 63 × oil immersion objective lens for 
imaging. Laser beams with 364, 488 and 543 nm excita-
tion wavelengths were used to image nuclei, SiNPs and 
actin respectively. 
2.8 Flow cytometry 
Caco-2 and CCD cells were seeded on 24 well plates at a 
density of 5×104 cells per well and treated with thiourea and 
amine capped SiNPs at a concentration of 100 µg/mL from 30 
minutes to 8 hours. The cells were trypsinized and then 
washed three times with PBS followed by centrifugation at 
1200 rpm for 5 min after each washing. Cells were fixed with 
4% (v/v) PFA in FBS for 20 min and washed again with PBS. 
Prior to the flow cytometric measurement, the cells were re-
suspended in a buffer of 5 % (v/v) FBS in PBS. The uptake of 
NPs was examined in 10,000 gated cells by detecting SiNPs 
fluorescence using FL1 channel detector and a BD FACSCali-
bur (BD Bioscience). Measurements were performed in tripli-
cate (with different sets of NPs) and data was analyzed with 
CellQuest Pro® software (BD Biosciences) and presented as 
median ± SD.  
2.9 Statistical analysis 
Statistical methods throughout this study are represented as 
mean ± SEM taken over a minimum of three independent ex-
periments. Statistical significance was measured by two-way-
ANOVA followed by a Bonferroni post-test using GraphPad 
Prism version 5.03 for Windows, GraphPad Software, San 
Diego California USA. 
 
3. Results and discussion 
3.1 Synthesis of thiourea-functionalized SiNPs 
Conjugation of thiourea onto SiNPs has high potential for 
the active targeting of EGFR overexpressing cancer cells. This 
can therefore increase the stability of silicon, enhance the na-
noparticle cell uptake and reduce the fast clearance of the na-
noparticles from the body since the capping ligand renders 
hydrogen terminated SiNPs hydrophilic to provide stable dis-
persions. In order to evaluate the potential of such systems, a 
ligand containing a thiourea segment was synthesized via the 
reaction between sulforaphane and allylamine and subsequent-
ly used to functionalize the surface of hydrogen terminated 
SiNPs obtained from the electrochemical top down method as 
previously described (Scheme 1). 
3.2 Fourier transform infrared spectroscopy (FTIR) 
The FTIR spectra of Sulforaphane, thiourea and thiourea-
functionalized SiNPs are presented in Fig. 1. Absorption peak 
at 1012 represents S=O in the structure of Sulforaphane as the 
starting material. Vibrations related to C-N and C-S bonds can 
be seen at 1298 and 692 cm-1 respectively.37-38 The characteris-
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Fig. 1 FTIR spectra of (a) sulforaphane; (b) thiourea and (c) 
thiourea-functionalized SiNPs. The relevant features of 
each spectrum are  highlighted. 
 
tic feature of isothiocyanate functional group can be clearly 
observed as a prominent double peak at 2099 cm-1.39 These 
peaks disappeared after reacting with allylamine but the 
stretching frequencies related to N-C-N vibrations in thiourea 
group were found at 1545 cm-1. The band at 3279 cm-1 repre-
sent the stretching vibration of the N-H bond in the derivative 
thiourea.40 After surface functionalisation of SiNPs with thiou-
rea, a peak at 1258 cm-1 can be seen which is a strong indica-
tor of Si-C bonding.41 In addition, there was no evidence of Si-
H stretching at 2100 cm-1.16 Therefore, the thiourea ligand with 
a terminal double bond reacted with the hydrogen terminated 
silicon surface via hydrosilylation in order to give a covalent 
Si-C linkage on the surface of the nanoparticles. 
 
 
 
 
3.3 X-ray photoelectron spectroscopy (XPS) 
For further evidence of the nanoparticle structure, the sur-
face chemical bonding was investigated using the full survey 
and high resolution XPS spectroscopy. Fig. 2a shows the full 
survey of the photoelectron spectrum. The high resolution 
XPS spectra of Si2p, C1s, O1s and N1s regions taken on a thin 
film of thiourea-functionalized SiNPs are presented in Fig. 2b 
to e. Fig. 2b indicates that the Si2p spectrum is fitted with 
three components and a Shirley background. The three peaks 
are located at 101.95, 102.73 and 100.91 eV. The first peak is 
attributed to Si-C confirming the hydrogen on the surface of 
SiNPs is replaced with thiourea.34 The second peak at binding 
energy 102.73 eV is related to Si-O due to partial surface oxi-
dation under the ambient conditions.42 The third component at 
100.91 eV is assigned to Si-Si within silicon core of NPs.43-44 
The C1s spectrum is fitted with three components and a 
Shirley background, see Fig. 2c. The four peaks are appeared 
at 284.65, 284.04, 285.50 and 286.72 eV. The first component 
at 284.65 eV is attributed to C-C bonding. The second peak at 
284.04 eV related to the existence of C-Si and finally the last 
two peaks at 285.50 and 286.72 eV are assigned to C-H and C-
N respectively.45-46 The O1s spectrum is presented in Fig. 2d 
and fitted with three components and a Shirley background. 
The first peak is related to partial oxidation at 532.01 eV for 
Si-O. The second binding energy at 533.25 eV is attributed to 
some hydroxide O-H group. The last component of O1s spec-
trum is assigned to O-S at 531.10 eV.44 The N1s spectrum is 
presented in Fig. 2e and fitted with two components and a 
Shirley background. The peak at 399.58 eV is assigned to C-N 
bonding in the thiourea. The other peak at 398.67 eV is at-
tributed to N-C=S.47 According to the surface chemistry data 
obtained from XPS the surface of SiNPs is fully capped with 
the ligand. A table with the quantification of XPS data can be 
seen in Table S1 in the supporting information. 
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Fig. 2 XPS spectra obtained from thiourea-functionalized SiNPs. (a) Full survey (b) Si2p (c) C1s (d) O1s (e) N1s. The 
dotted lines are experimental data that are fitted with different components.  
 
 3.4 Size measurement and stability  
Fig. 3a illustrates a TEM image of thiourea-functionalized 
SiNPs on a carbon coated copper grid. A mean size and size 
distribution was found to be  4.5 nm after analyzing 
approximately 100 SiNPs from different regions of the grid. 
(Fig. 3b) The insert figure shows the crystalline structure of 
the individual NPs. The mean hydrodynamic diameters of 
thiourea-functionalized SiNPs are represented in Table 1, in 
different solvents: water, PBS as well as the cell culture media 
RPMI and RPMI/10% FBS.  According to the data, SiNPs 
show almost the same average diamaters in all solvents. This 
is more than double than the core size of SiNPs due to the 
formation of an outer shell after the interaction between the 
capping ligand and the surrounding environment.48 However, 
the average diameter and the polydispersity index (PDI) are 
slightly increased for NPs in the RPMI containing 10% FBS, 
suggesting the expected adsorption of serum proteins on the 
surface of positively-charged SiNPs. This is because of the 
small size of SiNPs and their large surface area which lead to 
partial aggregation in the biological media, and therfore the 
presence of protiens reduces the surface energy. Nevertheless, 
the aggregation was not significant as the main population of 
the SiNPs was still observed around the expected sizes similar 
to other solvents less than 20 nm. The Zeta potential of NPs 
was measured in water and found to be 21  ± 0.80 mV. The 
surface charge of thiourea-functionalized SiNPs was tested in 
human plasma to investigate the effect of protein adsorption 
on Zeta potential values of NPs (see Fig. S1 in supporting 
information).  
 
3.5 Absorption and luminescence spectroscopy 
Absorption and emission spectra of thiourea-functionalized 
SiNPs are presented in Fig. 4. The inset photograph is the 
sample under UV illumination at 254 nm. NPs were dispersed 
in EtOH prior to the measurement as this improved the solu-
bility of the sample. The gradual increase in the absorbance 
with decreasing excitation wavelength from the onset wave-
length of 430 nm, corresponding to the absorption edge of 
2.88 eV, is characteristic of absorption across the indirect band 
gap of silicon.23 The solid line shows the photoluminescence 
spectrum of thiourea-functionalized SiNPs with the maximum 
emission peak centre at approximately 420 nm and a full width 
at half-maximum height (FWHM) of 79 nm under an excita-
tion wavelength of 340 nm. 
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Fig. 3 (a) TEM image of thiourea-functionalized silicon nanoparticles. The insert shows an enlarge view of the high resolution 
image of the crystalline structure. (b) the corresponding histogram of nanoparticle size distribution after analyzing 88 particles.    
 
Table 1 Mean hydrodynamic diameters and zeta potential of thiourea-functionalized SiNPs measured by DLS in different 
media. 
Solvent Mean particle Size (nm) ± SD Polydispersity index ± SD Zeta potential (mV) ± SD 
Water 11.32 ± 1.30 0.16 ± 0.05 21  ± 0.80 
PBS 12.20 ± 1.05 0.22 ± 0.05 NA 
RPMI 12.50 ± 1.26 0.20 + 0.10 NA 
RPMI/10% FBS 16.70 ± 4.08 0.33 ± 0.04 NA 
 
(a) 
   
 
 
A fluorescence quantum yield (QY) of 9.94% was measured 
by a comparative method described by Williams et al,49 using 
quinine sulphate in 0.1 M H2SO4 as reference (Fig. S2). 
In order to have a more efficient system in terms of biomed-
ical applications, it is important to obtain NPs with suitable PL 
stability. The long term stability of the synthesized SiNPs in 
EtOH was tested over a month and it was found that NPs can 
maintain about 80% of their initial PL after 30 days (Fig. 5a). 
The stabilization of the PL by the coating ligand is attributed 
to the covalent passivation of the surface by the thiourea 
which can prevent the oxidation of the NP surface.  
The pH is a fundamental parameter for biomedical uses, and 
thus the PL stability of thiourea-functionalized SiNPs was 
tested over a range of different pH values. Fig. 5b represents 
the changes in the intensity and peak wavelength of SiNPs in 
various pH values from 4 to 9. Based on the data obtaied, the 
photoluminescence intensity was stable over a range of 
physiologically relevant pH environment. Additionally, for pH 
levels 4-8 the peak position of the maximum PL emission 
remained unchanged, however for the most alkali pH 9 this 
shifted slightly to a lower wavelength (see Fig. S3) This 
indicates the role of the inorganic capping ligand to isolate the 
silicon core from the surrounding environment and thereore 
makes SiNPs suitable for further biomedical investigations. 
 
3.6 Cytotoxicity assay by MTT 
Modifying the surface chemistry of NPs, given their large 
surface area, alters the toxicity and biological characteristics 
which can be beneficial for biomedical applications. In this 
study, the cytotoxicity of thiourea-functionalized SiNPs in 
colon cancer cells and their equivalent normal cell line 
is evaluated by MTT assay. Amine-functionalized SiNPs, 
which have been identified as a non-toxic biomaterial,50 were 
used in this project as a control compound. Cells were exposed 
to increasing concentrations ranging from 5 to 1500 µg/mL 
thiourea and amine-functionalized SiNPs.  After 24 hours in-
cubation, a MTT assay was carried out in Caco-2 and CCD 
cells and the absorbance values were normalized to the un-
treated cells. The results indicate that for the NPs used in the 
current study, concentrations up to 1500 µg/mL did not show 
any significant toxicity after 24 h incubation (Fig. 6a and b). 
For this time point, both thiourea and amine- functionalized 
SiNPs reduced CCD and Caco-2 cell viability by approximate-
ly 20-25%, which indicates that the anticancer activity of thio-
urea did not develop in this short incubation time. In Caco-2 
cells, thiourea-functionalized SiNPs had a slightly larger ef-
fect than amine-functionalized SiNPs for concentrations 
around 50 µg/mL. For the longer 72 hours exposure (Fig. 6c 
and d), the Caco-2 cell viability dropped by 60% for concen-
trations above 100 µg/mL, a result that was not reproduced by 
amine-functionalized SiNPs which had negligible effect be-
yond 24 hours. Lower cell viability was observed at lower 
concentrations of thiourea-functionalized SiNPs in Caco-2 
cells than in CCD, which is important if the treatment is to be 
effective whilst having a less impactful effect on normal 
cells. In CCD cells the behaviour was similar for both thiourea 
and amine-functionalized SiNPs.  
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Fig. 4 Absorption and emission spectra of thiourea-
functionalized SiNPs at excitation at 340 nm. The inset 
image shows the fluorescence from a vial of sample in 
EtOH when excited with a UV lamp. 
 Day 1
 Day 5
 Day 15
 Day 20
 Day 25
 Day 30
350 400 450 500 550 600 650
0
100
200
300
400
500
600
700
800
900
1000
In
te
n
s
it
y
 (
a
.u
.)
Wavelength (nm)
(a)
 Day 10
 
350 400 450 500 550 600 650
In
te
n
s
it
y
 (
a
.u
.)
 
 
Wavelength (nm)
 pH 4
(b)
0
100
200
300
400
500
600
700
800
900
1000
 
 pH 9
 pH 6
 pH 5
 pH 7
 pH 8
 
 
Fig. 5 (a) Long term PL stability of thiourea-functionalized 
SiNPs stored in EtOH. (b) PL stability of thiourea-
functionalized SiNPs in buffers of different pH values.  
 
 
  
The high dosage of nanoparticles to be effective in this case 
may not seem to be appropriate (1500 µg/mL), however, it 
should be mentioned that the concentration used for the MTT 
assay is calculated with the whole entity of functionalized 
SiNPs, i.e. drug with the covalently bonded silicon core and 
based on the TGA data shown in the supporting information 
(Fig. S4) almost 60 % on the concentration is attributed to the 
silicon. Therefore, for thiourea-functionalized SiNPs to be 
more effective in terms of the cytotoxic effects, a higher dose 
of nanoparticles is needed (more than 100 µg/mL). In addition, 
the low intrinsic toxicity of silicon in nature, would make the 
application of SiNPs at such high dosage possible as there 
would be not much concern regarding the safety of silicon 
used in these multifunctional nanomaterials. 
 
3.7 Cellular uptake studies 
In order to understand the uptake behaviour of thiourea-
functionalized SiNPs at the cellular level, the cellular internal-
ization and intercellular distribution of NPs were evaluated by 
confocal imaging. Fig. 7 shows the confocal images of Caco-2 
cells incubated with 100 µg/mL of thiourea-functionalized 
SiNPs for 4 h at 37 oC compared to untreated control cells. 
Based on the images obtained, thiourea-functionalized SiNPs 
were successfully internalized within the cell cytoplasm as 
shown by the green fluorescence. For further evidence of the 
internal distribution of SiNPs, Z-stack images are shown in 
supplementary information (Fig. S5).  
 
3.8 Flow cytometry 
For additional SiNP uptake evidence, flow cytometry was 
used in both cancer and normal cells to semi-quantitavely 
measure cellular uptake of the NPs (see Fig. 8).  
The two well-known cell lines, Caco-2 and CCD-841, were 
chosen because of their different expression of EGFR. In liter-
ature, Caco-2 cells have been shown to overexpress the EGFR 
mRNA to almost 5 fold when normalized to the CCD cells as 
control, while CCD cells did not show EGFR overexpression 
and lacked observable EGFR phosphorylation.51  
Thiourea and amine-functionalized SiNPs (each 100 
µg/mL) were incubated with both cells (Caco-2 and CCD) for 
five different time periods (from 30 min to 8 h). Median fluo-
rescence values demonstrate cell uptake of thiourea and 
amine-functionalized SiNPs. The data has confirmed consid-
erably more uptake of thiourea-functionalized SiNPs in Caco-
2 cells compared to amine-functionalized SiNPs for all time 
points (Fig 8a). Moreover, the fluorescent signal of thiourea-
functionalized SiNPs increased gradually between 30 min and 
4 h. At 4 h exposure the maximal thiourea-functionalized 
SiNP uptake was observed, where longer time (6 and 8 h) did 
not increase the cellular uptake. This suggests that thiourea-
  
  
 
Fig. 6 In vitro cytotoxicity of thiourea and amine capped SiNPs by MTT after incubation with Caco-2, 24 h (a), CCD,24 h (b), 
Caco-2, 72 h (c) and CCD   for 72 h incubation (d) at 37 oC. (The results were normalized to non-stimulated cells.) Statistical 
significance was determined by two-way-ANOVA followed by a Bonferroni post-test. (*P < 0.05, ***P < 0.001, ns statistically 
not significant).  Results are expressed as mean ± SEM (n =3). 
 
 functionalized SiNPs reached an uptake saturation level, 
whereas the non-specific cellular uptake of amine-
functionalized SiNPs increased overtime. A plausible explana-
tion for this result, consistent with previous known character-
istics of thiourea-functionalized SiNPs, is that the thiourea-
functionalized SiNP uptake mechanism is through the recep-
tor-mediated endocytosis by the interaction with EGFR as the 
cell internalization in this case can occur within the early 
hours of receptor stimulation.52 Amine-functionalized SiNPs 
on the other hand have no known similar interaction, and thus 
the lower levels of internalization are reached through passive, 
rather than active targeting. Since a saturation level was 
reached for thiourea-functionalized SiNPs, it is more likely 
that EGFR are transported to endosome/lysosome for degrada-
tion rather than the possibility of the receptor recycling pro-
cess which would lead to the increase of uptake overtime.53 
The introduction of thiourea-functionalized SiNPs in cancer 
cells therefore can potentially manage the multiple cellular 
processes in which EGFR is a key player and thus an inhibit 
tumour growth. However, the level of thiourea-functionalized 
SiNP uptake in CCD cells seemed to be much lower (Fig. 8b). 
A higher florescence was observed at the shorter time point of 
1 h incubation. For longer incaution times, up to 8 h exposure, 
the uptake decreased. 
One possible explanation for this behaviour could be that 
the presence of the ligand caused some steric alteration which 
reduced the uptake of thiourea- SiNPs for longer exposure. 
This may be compounded by the fact that expression of EGFR 
in primary epithelial colon cells is less than cancer cells.54   
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Fig. 7 Confocal fluorescence images of Caco-2 cells incubated with thiourea capped SiNPs for 4 h compared to control (un-
treated) cells (top row). Blue from Hoechst for nuclei, red from Phalloidin for actin staining and green fluorescence from thiou-
rea capped SiNPs.  
 4. Conclusions 
We reported here the synthesis of thiourea-functionalized 
SiNPs as a novel nanodelivery system, which can be actively 
targeted towards cancer cells that over express of EGFR.  This 
approach makes use of the physiochemical and biological 
properties of both components of the nanosystem, in particular 
the photoluminescence of SiNPs and the anticancer activity of 
thiourea. According to the FTIR and elemental analysis, SiNPs 
are fully capped with the thiourea ligand. The stability of 
SiNPs in different biological media, as a result of the covalent 
conjugation of the ligand on the surface of nanoparticles, was 
shown by DLS. This result has addressed the challenges re-
garding the long term stability of nanoparticles for similar 
biomedical applications. The in vitro toxicity of the novel na-
noparticles was verified by MTT assay in colorectal cancer 
and normal cells. The thiourea-functionalized SiNPs were 
shown to be toxic after 72 hours exposure to the cancer cells. 
Considering the data obtained from uptake studies in both 
Caco-2 and CCD cells, it was shown that thiourea-
functionalized SiNPs were distributed within the cytoplasm as 
visualized in confocal images. The uptake of thiourea-
functionalized SiNPs was found to show a time dependent 
behavior. The fluorescent signal increased gradually between 
30 min and 4 h. The saturation uptake level suggested the lig-
and binds with the receptor and therefore the degradation of 
EGFR after 4 hours is most likely to occur. This is significant 
in term of developing future diagnostic tools for drug delivery 
systems. Overall, the nanodelivery system developed herein 
presents an encouraging platform for drug delivery particular-
ly aiming for the targeting of EGFR overexpression in cancer 
cells. 
 
 
SUPPORTING INFORMATION 
Synthesis of amine terminated SiNPs, Stability in human plasma 
including zeta potential of SiNPs in human plasma at different 
time points, Quantum Yield measurements, PL stability in differ-
ent pH buffer, TGA analysis with the spectra showing TGA and 
derivative of SiNPs, Z-stack confocal imaging, data from Elisa 
assay, and the XPS fitting data. This material is available free of 
charge via the Internet at http://pubs.acs.org. 
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